3,382
Views
51
CrossRef citations to date
0
Altmetric
Original Articles

Ciprofloxacin HCl-loaded calcium carbonate nanoparticles: preparation, solid state characterization, and evaluation of antimicrobial effect against Staphylococcus aureus

, , , &
Pages 535-543 | Received 22 Nov 2015, Accepted 29 Feb 2016, Published online: 25 Mar 2016

References

  • Adams K, Couch L, Cierny G, Calhoun J, Mader JT. 1992. In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthopaed Rel Res. 278:244–252.
  • Adibkia K, Alaei-Beirami M, Barzegar-Jalali M, Mohammadi G, Ardestani MS. 2012. Evaluation and optimization of factors affecting novel diclofenac sodium-eudragit RS100 nanoparticles. Afr J Pharm Pharmacol. 6:941–947.
  • Adibkia K, Javadzadeh Y, Dastmalchi S, Mohammadi G, Niri FK, Alaei-Beirami M. 2011. Naproxen–Eudragit® RS100 nanoparticles: preparation and physicochemical characterization. Colloid Surf B: Biointer. 83:155–159.
  • Ahangari A, Salouti M, Heidari Z, Kazemizadeh AR, Safari AA. 2013. Development of gentamicin-gold nanospheres for antimicrobial drug delivery to Staphylococcal infected foci. Drug Deliv. 20:34–39.
  • Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M. 2011. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther. 9:1035–1052.
  • Andreassen J-P. 2005. Formation mechanism and morphology in precipitation of vaterite—nano-aggregation or crystal growth? J Crystal Grow. 274:256–264.
  • Barzegar-Jalali M. 1990. A model for linearizing drug dissolution data. Int J Pharm. 63:R9–R11.
  • Barzegar-Jalali M, Adibkia K, Valizadeh H, Shadbad MRS, Nokhodchi A, Omidi Y, et al. 2008. Kinetic analysis of drug release from nanoparticles. J Pharm Pharm Sci. 11:167–177.
  • Barzegar-Jalali M, Valizadeh H, Nazemiyeh H, Barzegar-Jalali A, Shadbad MRS, Adibkia K, Zare M. 2010. Reciprocal powered time model for release kinetic analysis of ibuprofen solid dispersions in oleaster powder, microcrystalline cellulose and crospovidone. J Pharma Pharm Sci. 13:152–161.
  • Benoit M-A, Mousset B, Delloye C, Bouillet R, Gillard J. 1998. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Int Orthopaed. 21:403–408.
  • Berne BJ, Pecora R. 2000. Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics. New York: John Wiley & Sons Publisher.
  • Biazar E, Heidari Keshel S, Tavirani MR, Jahandideh R. 2015. Bone reconstruction in rat calvarial defects by chitosan/hydroxyapatite nanoparticles scaffold loaded with unrestricted somatic stem cells. Artif Cells Nanomed Biotechnol. 43:112–116.
  • Beyssac E, Lavigne J. 2005. Dissolution study of active pharmaceutical ingredients using the flow through apparatus USP 4. Dissolut Technol. 12:23–25.
  • Blokhuis TJ, Termaat MF, Den Boer FC, Patka P, Bakker FC, Henk JTM. 2000. Properties of calcium phosphate ceramics in relation to their in vivo behavior. J Trauma Acute Care Surg. 48:179–186.
  • Brunton LL. 2011. Goodman & Gilman's the Pharmacological basis of therapeutics. New York: McGraw-Hill.
  • Cevher E, Orhan Z, Sensoy D, Ahiskali R, Kan PL, Sagirli O, Mülazimoglu L. 2007. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis. J Microencapsul. 24:577–595.
  • Chen J, Xiang L. 2009. Controllable synthesis of calcium carbonate polymorphs at different temperatures. Powder Technol. 189:64–69.
  • Clogston JD, Patri AK. 2011. Zeta potential measurement. Method Mol Biol. 697:63–70.
  • Cooper J, Hunt J. 2006. The significance of zeta potential in osteogenesis. Annual Meeting in conjunction with the 25th International Biomaterials Symposium. p. 592.
  • Darvishi B, Manoochehri S, Kamalinia G, Mostafavi SH, Maghazei S, Samadi N, et al. 2014. Preparation and antibacterial activity evaluation of 18-β-glycyrrhetinic acid loaded PLGA nanoparticles. Iran J Pharm Res. 14:373–383.
  • Dillen K, Vandervoort J, Van Den Mooter G, Ludwig A. 2006. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm. 314:72–82.
  • Dillen K, Vandervoort J, Van Den Mooter G, Verheyden L, Ludwig A. 2004. Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int J Pharms. 275:171–187.
  • Dizaj SM, Barzegar-Jalali M, Zarrintan MH, Adibkia K, Lotfipour F. 2015a. Calcium carbonate nanoparticles as cancer drug delivery system. Exp Opin Drug Deliv. 12:1649–1660.
  • Dizaj SM, Lotfipour F, Barzegar-Jalali M, Zarrintan M-H, Adibkia K. 2015b. Application of Box–Behnken design to prepare gentamicin-loaded calcium carbonate nanoparticles. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1042108.
  • Dizaj SM, Lotfipour F, Barzegar-Jalali M, Zarrintan MH, Adibkia K. 2014. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater Sci Eng C Mater Biol Appl. 44:278–284.
  • Dizaj SM, Mennati A, Jafari S, Khezri K, Adibkia K. 2015c. Antimicrobial activity of carbon-based nanoparticles. Adv Pharm Bull. 5:19–23.
  • Drlica K, Zhao X. 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 61:377–392.
  • Eğri S, Eczacıoğlu N. 2016. Sequential VEGF and BMP-2 releasing PLA-PEG-PLA scaffolds for bone tissue engineering: I. Design and in vitro tests. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2016.1147454.
  • Esmaeili F, Hosseini-Nasr M, Rad-Malekshahi M, Samadi N, Atyabi F, Dinarvand R. 2007. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Nanomed Nanotechnol Biol Med. 3:161–167.
  • Giamarellos-Bourboulis EJ. 2000. Carrier systems for the local delivery of antibiotics in bone infections. Drugs. 59:1223–1232.
  • Gürsel I, Korkusuz F, Türesin F, Gürdal Alaeddinoğlu N, Hasırcı V. 2000. In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. Biomaterials. 22:73–80.
  • Haruta S, Hanafusa T, Fukase H, Miyajima H, Oki T. 2003. An effective absorption behavior of insulin for diabetic treatment following intranasal delivery using porous spherical calcium carbonate in monkeys and healthy human volunteers. Diabet Technol Therapeut. 5:1–9.
  • Honary S, Jahanshahi M, Golbayani P, Ebrahimi P, Ghajar K. 2010. Doxorubicin-loaded albumin nanoparticles: formulation and characterization. J Nanosci Nanotechnol. 10:7752–7757.
  • Honary S, Zahir F. 2013. Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2). Trop J Pharm Res. 12:265–273.
  • Jahangiri A, Davaran S, Fayyazi B, Tanhaei A, Payab S, Adibkia K. 2014. Application of electrospraying as a one-step method for the fabrication of triamcinolone acetonide-PLGA nanofibers and nanobeads. Colloids Surf B Biointerfaces. 123:219–224.
  • Jain SK, Prajapati N, Rajpoot K, Kumar A. 2015. A novel sustained release drug–resin complex-based microbeads of ciprofloxacin HCl. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1111233.
  • Jana U, Mohanty AK, Pal SL, Manna PK, Mohanta GP. 2014. Felodipine loaded PLGA nanoparticles: preparation, physicochemical characterization and in vivo toxicity study. Nano Convergence. 1:1–10.
  • Jeong Y-I, Na H-S, Seo D-H, Kim D-G, Lee H-C, Jang M-K, et al. 2008. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity. Int J Pharm. 352:317–323.
  • Kadivar A, Kamalidehghan B, Javar HA, Davoudi ET, Zaharuddin ND, Sabeti B, Chung LY, Noordin MI. 2015. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet. PLoS One. 10:e0126874.
  • Kalam M, Humayun M, Parvez N, Yadav S, Garg A, Amin S, Sultana Y, Ali A. 2007. Release kinetics of modified pharmaceutical dosage forms: a review. Cont J Pharm Sci. 1:30–35.
  • Kamba SA, Ismail M, Hussein-Al-Ali SH, Ibrahim TT, Zakaria ZB. 2013. In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer. Molecules. 18:10580–10598.
  • Kesavan K, Nath G, Pandit J. 2010. Preparation and in vitro antibacterial evaluation of gatifloxacin mucoadhesive gellan system. DARU. 18:237.
  • Kirboga S, Oner M. 2013. Effect of the experimental parameters on calcium carbonate precipitation. Chem Eng. 32:2119–2124.
  • Koort J, Suokas E, Veiranto M. 2006. In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment. J Biomed Mater Res A. 78:532–540.
  • Korkusuz F, Korkusuz P, Ekşioĝlu F, Gürsel İ, Hasırcı V. 2001. In vivo response to biodegradable controlled antibiotic release systems. J Biomed Mater Res. 55:217–228.
  • Kumar G, Sharma S, Shafiq N, Khuller GK, Malhotra S. 2012. Optimization, in vitro–in vivo evaluation, and short-term tolerability of novel levofloxacin-loaded PLGA nanoparticle formulation. J Pharm Sci. 101:2165–2176.
  • Lucas A, Gaudé J, Carel C, Michel J-F, Cathelineau G. 2001. A synthetic aragonite-based ceramic as a bone graft substitute and substrate for antibiotics. Int J Inorgan Mater. 3:87–94.
  • Mo Y, Lim L-Y. 2005. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J Control Release. 108:244–262.
  • Mobarak DH, Salah S, Elkheshen SA. 2014. Formulation of ciprofloxacin hydrochloride loaded biodegradable nanoparticles: optimization of technique and process variables. Pharm Dev Technol. 19:891–900.
  • Montaseri H, Sayyafan M, Tajerzadeh H. 2010. Preparation and characterization of poly-(methyl ethyl cyanoacrylate) particles containing 5-aminosalicylic acid. Iran J Pharm Res. 1:21–27.
  • Neut D, Van De Belt H, Van Horn JR, Van Der Mei HC, Busscher HJ. 2003. Residual gentamicin-release from antibiotic-loaded polymethylmethacrylate beads after 5 years of implantation. Biomaterials. 24:1829–1831.
  • Ni M, Ratner BD. 2008. Differentiating calcium carbonate polymorphs by surface analysis techniques—an XPS and TOF‐SIMS study. Surf Int Anal. 40:1356–1361.
  • Nokhodchi A, Mohammadi G, Ghafourian T. 2012. Nanotechnology Tools for Efficient Antibacterial Delivery to Salmonella. New York: InTech Open Access Publisher.
  • Ofoefule S, Chukwu A. 2002. Sustained release dosage forms: design and evaluation of oral products. In: Ofoefule SI, Ed. Textbook of Pharmaceutical Technology and Industrial Pharmacy. Lagos, Nigeria: Samakin (Nig.) Enterprises, pp. 94–120.
  • Perry CR, Rice S, Ritterbusch JK, Burdge RE. 1985. Local administration of antibiotics with an implantable osmotic pump. Clin Orthopaedic Relat Res. 192:284–290.
  • Qian K, Shi T, Tang T, Zhang S, Liu X, Cao Y. 2011. Preparation and characterization of nano-sized calcium carbonate as controlled release pesticide carrier for validamycin against Rhizoctonia solani. Microchim Acta. 173:51–57.
  • Sah E, Sah H. 2015. Recent trends in preparation of poly(lactide-co-glycolide) nanoparticles by mixing polymeric organic solution with antisolvent. J Nanomater. 2015:1–22.
  • Sahoo S, Chakraborti CK, Mishra SC. 2011. Qualitative analysis of controlled release ciprofloxacin/carbopol 934 mucoadhesive suspension. J Adv Pharm Technol Res. 2:195–204.
  • Salouti M, Ahangari A. 2014. Nanoparticle Based Drug Delivery Systems for Treatment of Infectious Diseases. New York: InTech.
  • Shen Y, Xie A, Chen Z, Xu W, Yao H, Li S, et al. 2007. Controlled synthesis of calcium carbonate nanocrystals with multi-morphologies in different bicontinuous microemulsions. Mater Sci Eng: A. 443:95–100.
  • Silverstein RM, Webster FX, Kiemle D, Bryce DL. 2014. Spectrometric Identification of Organic Compounds. New York: John Wiley & Sons.
  • Smeets R, Kolk A, Gerressen M, Driemel O, Maciejewski O, Hermanns-Sachweh B, et al. 2009. A new biphasic osteoinductive calcium composite material with a negative Zeta potential for bone augmentation. Head Face Med. 5:13.
  • Solberg BD, Gutow AP, Baumgaertner MR. 1999. Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model. J Orthopaed Trauma. 13:102–106.
  • Tai CY, Chen C-K. 2008. Particle morphology, habit, and size control of CaCO3 using reverse microemulsion technique. Chem Eng Sci. 63:3632–3642.
  • Teng N, Nakamura S, Takagi Y, Yamashita Y, Ohgaki M, Yamashita K. 2001. A new approach to enhancement of bone formation by electrically polarized hydroxyapatite. J Dent Res. 80:1925–1929.
  • Ueno Y, Futagawa H, Takagi Y, Ueno A, Mizushima Y. 2005. Drug-incorporating calcium carbonate nanoparticles for a new delivery system. J Control Release. 103:93–98.
  • Ukrainczyk M, Kontrec J, Babić-Ivančić V, Brečević L, Kralj D. 2007. Experimental design approach to calcium carbonate precipitation in a semicontinuous process. Powder Technol. 171:192–199.
  • Ukrainczyk M, Kontrec J, Kralj D. 2009. Precipitation of different calcite crystal morphologies in the presence of sodium stearate. J Colloid Interface Sci. 329:89–96.
  • Uskoković V, Desai TA. 2014. Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus. Mater Sci Eng C. 37:210–222.
  • Vogelman B, Gudmundsson S, Leggett J, Turnidge J, Ebert S, Craig W. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis. 158:831–847.
  • Waldvogel FA, Medoff G, Swartz MN. 1970. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Eng J Med. 282:316.
  • Wang Y, Moo YX, Chen C, Gunawan P, Xu R. 2010. Fast precipitation of uniform CaCO3 nanospheres and their transformation to hollow hydroxyapatite nanospheres. J Colloid Interface Sci. 352:393–400.
  • Zhang L, Pornpattananangkul D, Hu C-M, Huang C-M. 2010. Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem. 17:585–594.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.